“Metformin slows aging in healthy people.”
Metformin has not been shown to slow aging in healthy people, and in healthy older adults it held back the benefits of exercise.
If you are healthy, taking metformin to slow aging has no proven benefit and may cost you some of the muscle and fitness you gain from exercise. Regular strength and aerobic training are the proven way to stay strong and healthy as you age.
Skip metformin as an anti-aging pill, and put that effort into two or more strength workouts a week.
Safety note: In healthy older adults, metformin reduced the muscle and fitness gains people got from exercise. Common side effects are nausea, diarrhea and other stomach upset. Long-term use can lower vitamin B12, the dose depends on kidney function, and a rare but serious problem called lactic acidosis is more likely in specific high-risk settings, such as poor kidney function.
Talk to a healthcare professional if: you are thinking about taking metformin to slow aging, or you have prediabetes or diabetes and want to know whether it fits your situation. A prescriber can check your kidney function and B12 and weigh the drug against what exercise is already doing for you.
Trials of metformin in older adults without diabetes have found no benefit on aging-related measures, and two found it held back gains from exercise. Confidence is Limited because those trials were small and short, and no trial has yet measured aging itself in healthy people.
Metformin has not been shown to slow aging in healthy people, and in healthy older adults it held back the benefits of exercise. In a 14-week trial of 94 healthy adults aged 65 and older doing strength training, those on metformin gained less lean mass and thigh muscle than those on placebo. In a 12-week trial of 53 older adults doing aerobic exercise, metformin blocked the rise in muscle mitochondrial function and dulled the gains in insulin sensitivity and fitness.
The longevity idea for metformin came from animal studies, cell research and observational studies of people with diabetes. A 2025 review found that some of the most cited observational findings had built-in biases and did not hold up when checked again, and that most trials in people without diabetes, covering frailty, heart disease and cancer, did not show the hoped-for benefits. Metformin remains a proven, low-cost medicine for type 2 diabetes.
- Keys MT, Hallas J, Miller RA, Suissa S, Christensen K. Emerging uncertainty on the anti-aging potential of metformin. Ageing Research Reviews. 2025;111:102817. DOI: 10.1016/j.arr.2025.102817. PMID: 40582648. PMCID: PMC13329735
- Walton RG, Dungan CM, Long DE, et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: a randomized, double-blind, placebo-controlled, multicenter trial: the MASTERS trial. Aging Cell. 2019;18(6):e13039. DOI: 10.1111/acel.13039. PMID: 31557380. PMCID: PMC6826125. ClinicalTrials.gov: NCT02308228
- Konopka AR, Laurin JL, Schoenberg HM, et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019;18(1):e12880. DOI: 10.1111/acel.12880. PMID: 30548390. PMCID: PMC6351883. ClinicalTrials.gov: NCT02552355
- Kulkarni AS, Brutsaert EF, Anghel V, et al. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. Aging Cell. 2018;17(2):e12723. DOI: 10.1111/acel.12723. PMID: 29383869. PMCID: PMC5847877